Search Results 1831-1840 of 21523 for platelets

1. Methadone versus Intrathecal Hydromorphone for Analgesia Patients Undergoing Surgery for Gynecologic Malignancy via Midline Laparotomy Receiving Liposomal Bupivacaine - Mayo Clinic

   * Preoperative platelets (PLT) \< 75 * Preoperative international normalized ratio (INR) \> 1.5 * Inappropriate cessation of anticoagulation medications ...

2. Safety and Tolerability of TAR-200 in Subjects With Muscle-Invasive Bladder Cancer Who Are Unfit for Radical Cystectomy - Mayo Clinic

   Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 2x the upper limit of normal (ULN);; Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ...

3. Spine Care - Doctors - Mayo Clinic

   Min Yoo, M.D.. Physiatrist. Phoenix, AZ. Areas of focus: Rehabilitation therapy, Ultrasound-guided musculoskeletal injection, Platelet rich plasma injection, ...

4. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Platelets > 100 × 109/L (100000/mm3);; Hemoglobin ≥ 10.0 g/dL (6.2 mmol/L);; Serum total bilirubin ≤ 1.5 × ULN (except subjects with Gilbert syndrome, who ...

5. Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer - Mayo Clinic

   Platelets (PLT) ≥ 100,000/mm^3; Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN); Creatinine ≤ 1.5 x institutional ULN; Aspartate ...

6. A Study of Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients with Previously Treated Multiple Myeloma or Plasma Cell Leukemia - Mayo Clinic

   Platelet count ≥ 50,000/mm^3; Hemoglobin ≥ 8.0 g/dL; Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2; Provide informed written ...

7. Study Of Lurbinectedin In Combination With Doxorubicin Versus Doxorubicin Alone As First-line Treatment In Participants With Metastatic Leiomyosarcoma - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL (patients may have received prior red blood cell [RBC] transfusion); absolute neutrophil count (ANC) ≥ 2.0 x 10^9 /L, and platelet count ...

8. An Efficacy, Safety And Tolerability Study Of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections To Subjects With Heart Failure Due To Ischemic Dilated Cardiomyopathy (IDCM) - Mayo Clinic

   Participation eligibility · Platelets < 50,000 μL · Hemoglobin < 9.0 g/dL · Aspartate aminotransferase/alanine aminotransferase (AST/ALT) > 3 times the upper limit ...

9. LS1681: A Study of AR160 in Treating Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Platelet count ≥ 75,000/mm^3. Hemoglobin ≥ 8.0g/dL. Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or if total bilirubinism. > 1.5 x ULN, the direct ...

10. A Study of TRK-950 in Patients With Advanced Solid Tumors - Mayo Clinic

    Platelet count ≥ 100,000 (plt/mm3);; Hemoglobin ≥ 9 g/dL. Urinalysis: No clinically significant abnormalities. Acceptable coagulation status: For the Dose ...